European heart journal. Cardiovascular Imaging · 2026
Left ventricular global longitudinal strain improves risk stratification in chronic aortic regurgitation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Bo, Liu Yujie, Dai Linlin, Zheng Yucong, Han Zijuan, Tang Yun, Chen Xingrui, Zhang Aoxiang, Ma Xuan, Zhou Pengyu, Jia Xi, Xu Wenqing, Aisikaier Kaisaierjiang, Han Shengyao, Sa Fen, Yang Kai, Zhao Kankan, Yan Chaowu, Chen Xiuyu, Zhao Shihua
Аннотация
AIMS: To evaluate the prognostic value of cardiac magnetic resonance (CMR) feature tracking-derived left ventricular global longitudinal strain (FT-LVGLS) for adverse outcomes in patients with chronic moderate to severe aortic regurgitation (AR), and to further assess its incremental prognostic value in predicting adverse outcomes beyond the 2025 ESC/EACTS Class I/IIb surgical indication parameters.
METHODS AND RESULTS: This retrospective cohort study initially screened 707 patients with at least moderate chronic AR who underwent CMR between 2010 and 2024, of whom 385 with no or minimal symptoms (NYHA class I-II; mean age 54.1 ± 13.5 years; 329 male) constituted the primary study cohort. The primary endpoint was major adverse cardiac events (MACE), defined as all-cause mortality, heart transplantation, unplanned hospitalization for heart failure, or implantable cardioverter defibrillator discharge. During a median follow-up of 52.9 months, 45 patients experienced MACE. Multivariable Cox regression identified FT-LVGLS as independently associated with MACE (adjusted HR: 1.210 per 1% decrease in absolute FT-LVGLS, P < 0.007). Incorporating FT-LVGLS into prognostic models containing each ESC/EACTS Class I/IIb surgical indication parameter (dichotomized by guideline-recommended thresholds) consistently improved model discrimination for MACE, with C-index increasing from 0.730-0.768 to 0.783-0.791 and likelihood ratio χ2 values from 36.04-41.12 to 50.10-52.07. Kaplan-Meier survival curves demonstrated that an absolute FT-LVGLS cut-off of 12% further refined risk stratification.
CONCLUSION: In NYHA class I-II patients with chronic moderate-to-severe AR, FT-LVGLS was independently associated with MACE and provided incremental prognostic value beyond ESC/EACTS guideline-based surgical indication parameters, supporting its potential role in improving risk identification.
METHODS AND RESULTS: This retrospective cohort study initially screened 707 patients with at least moderate chronic AR who underwent CMR between 2010 and 2024, of whom 385 with no or minimal symptoms (NYHA class I-II; mean age 54.1 ± 13.5 years; 329 male) constituted the primary study cohort. The primary endpoint was major adverse cardiac events (MACE), defined as all-cause mortality, heart transplantation, unplanned hospitalization for heart failure, or implantable cardioverter defibrillator discharge. During a median follow-up of 52.9 months, 45 patients experienced MACE. Multivariable Cox regression identified FT-LVGLS as independently associated with MACE (adjusted HR: 1.210 per 1% decrease in absolute FT-LVGLS, P < 0.007). Incorporating FT-LVGLS into prognostic models containing each ESC/EACTS Class I/IIb surgical indication parameter (dichotomized by guideline-recommended thresholds) consistently improved model discrimination for MACE, with C-index increasing from 0.730-0.768 to 0.783-0.791 and likelihood ratio χ2 values from 36.04-41.12 to 50.10-52.07. Kaplan-Meier survival curves demonstrated that an absolute FT-LVGLS cut-off of 12% further refined risk stratification.
CONCLUSION: In NYHA class I-II patients with chronic moderate-to-severe AR, FT-LVGLS was independently associated with MACE and provided incremental prognostic value beyond ESC/EACTS guideline-based surgical indication parameters, supporting its potential role in improving risk identification.